Search Results

IGC Spotlight

Spotlight on the 2025 IGC

Updates from the annual Interventional Glaucoma Consortium.

Case Files

To Treat or Not to Treat

Clinicians discuss how to approach the management of a young patient with normal-tension glaucoma, high myopia, and sleep apnea.

Devesh K. Varma, MD, FRCSC; Ahmad A. Aref, MD, MBA; James T. Murphy, MD; and Rachel G. Simpson, MD

Case Files

Pigment Dispersion Glaucoma

The iridotomy dilemma.

Devesh K. Varma, MD, FRCSC; Shan C. Lin, MD; James Liu, MD; and Kelly W. Muir, MD, MHSc

The Literature

Saving the Optic Nerve

Studying neuroregeneration and neuroprotection.

Melissa L. Cooper, BS, and David J. Calkins, PhD

The Literature

Jessica S. Maslin, MD, and Ji Liu, MD

Vascular Considerations in Glaucoma Management

Evidence strongly suggests that ocular blood flow plays a role in glaucoma pathophysiology.

Alon Harris, MS, PhD; Rehan Hussain, MD; Scott Wentz; and Brent Siesky, PhD

The Literature

The Literature

Timothy W. Sullivan, MD, and Tak Yee Tania Tai, MD

The Literature

The Literature

Anjum Cheema, MD, and Anurag Shrivastava, MD

The literature

Ji Liu, MD

The Literature

Rajendra K. Bansal, MD

The Literature

The Literature

Thomas M. Grippo, MD

The Literature

SONYA THOMAS AND NILS A. LOEWEN, MD, PHD

The Literature

KRISTY AHRLICH, MD

Should We Measure (and Treat) Ocular Perfusion Pressure in Glaucoma Patients?

Mounting evidence indicates that this parameter may affect an individual patient's risk of developing glaucoma and/or its progression, but there are currently multiple challenges to and limitations on incorporating this concept into everyday clinical practice.

James C. Tsai, MD

Developments in Neuroprotection

Novel neuroprotective agents and their mechanisms.

Daniel Hwang, MA; Li Wu, MD; and James C. Tsai, MD

Developments in Neuroprotection

Novel neuroprotective agents and their mechanisms.

Daniel Hwang, MA; Li Wu, MD; and James C. Tsai, MD